View Older Stories View More Recent Stories

Jun 9, 2022 08:03AM PTC Therapeutics (PTCT) Appoints Alethia Young to its Board
Jun 9, 2022 08:00AM Biotech Investment Veteran Alethia Young Joins PTC Therapeutics' Board of Directors
Jun 6, 2022 08:00AM PTC Therapeutics to Participate at William Blair 42nd Annual Growth Stock Conference
Jun 3, 2022 08:00AM Preliminary Results Presented at ASCO Demonstrated Promising Clinical Efficacy with Unesbulin in Leiomyosarcoma Study
May 31, 2022 05:56AM PTC Therapeutics (PTCT) Announces FDA Label Extension of Evrysdi to Include Infants
May 31, 2022 01:00AM FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old
May 20, 2022 08:09AM PTC Therapeutics (PTCT) Receives Positive CHMP Opinion for Upstaza for the Treatment of AADC Deficiency
May 20, 2022 08:08AM PTC Therapeutics Receives Positive CHMP Opinion for Upstaza™ for the Treatment of AADC Deficiency
May 3, 2022 04:01PM PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results
Apr 29, 2022 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Apr 19, 2022 08:00AM PTC Therapeutics to Host Conference Call to Discuss First Quarter 2022 Financial Results
Apr 14, 2022 08:32AM PTC Therapeutics (PTCT) Issues Update on EMA Regulatory Review Timeline For Its AADC Deficiency Gene Therapy Program
Apr 14, 2022 08:30AM PTC Therapeutics Provides Update on EMA Regulatory Review Timeline For Its AADC Deficiency Gene Therapy Program
Apr 8, 2022 04:23PM PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 30, 2022 04:00PM PTC Therapeutics (PTCT) Initiates PIVOT-HD Phase 2 Clinical Trial to Evaluate PTC518 in Patients with Huntington's Disease
Mar 30, 2022 04:00PM PTC Therapeutics Announces Initiation of PIVOT-HD Phase 2 Clinical Trial to Evaluate PTC518 in Patients with Huntington's Disease
Mar 11, 2022 08:00AM PTC Therapeutics to Present New Data at the 2022 Muscular Dystrophy Association Clinical & Scientific Conference
Feb 23, 2022 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Feb 22, 2022 04:01PM PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 8, 2022 08:00AM PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2021 Financial Results
Jan 25, 2022 05:50AM PTC Therapeutics's (PTCT) Evrysdi Granted FDA Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy
Jan 25, 2022 01:00AM FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy
Jan 18, 2022 08:00AM PTC Therapeutics Announces Launch of 8th Annual STRIVE™ Awards Program to Fund Initiatives Benefitting the Duchenne Muscular Dystrophy Community
Jan 13, 2022 04:30PM PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 13, 2022 08:00AM PTC Therapeutics Announces Launch of 2022 Global Talent Pipeline Program
Jan 10, 2022 07:24AM PTC Therapeutics (PTCT) Provides Update on Commercial Progress and R&D Pipeline at 40th Annual J.P. Morgan Healthcare Conference
Jan 10, 2022 07:00AM PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 40th Annual J.P. Morgan Healthcare Conference
Jan 4, 2022 08:03AM PTC Therapeutics' (PTCT) Waylivra Receives Innovative Drug Category Pricing in Brazil
Jan 4, 2022 08:00AM Waylivra™ Receives Innovative Drug Category Pricing to Treat Familial Chylomicronemia Syndrome in Brazil
Jan 3, 2022 08:00AM PTC Therapeutics to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
Dec 20, 2021 08:00AM Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein Discovered Through PTC Therapeutics' Innovative Splicing Platform
Dec 6, 2021 09:13AM Evrysdi® Distinguished by Two Prestigious Awards for Outstanding Innovation in Drug Discovery
Dec 2, 2021 04:30PM PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 16, 2021 08:00AM PTC Therapeutics to Participate at Upcoming Virtual Investor Conference
Oct 28, 2021 04:00PM PTC Therapeutics Provides a Corporate Update and Reports Third Quarter 2021 Financial Results
Oct 26, 2021 08:00AM PTC Therapeutics to Participate at Upcoming Virtual Investor Conference
Oct 25, 2021 08:00AM PTC Announces Expansion of Translarna™ Label to Include Ambulatory Patients as Young as 2 Years Old in Brazil
Oct 14, 2021 08:58AM PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2021 Financial Results
Oct 14, 2021 08:30AM PTC Therapeutics Celebrates Opening of Gene Therapy Manufacturing Facility
Oct 11, 2021 08:00AM Tegsedi® Receives Innovative Drug Category Pricing in Brazil
Sep 29, 2021 08:00AM Results Show Long-Lasting and Holistic Improvements in Children with AADC Deficiency Treated with PTC-AADC Gene Therapy
Sep 20, 2021 04:34PM PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1 Study for Huntington's Disease Program
Sep 20, 2021 08:33AM PTC Therapeutics (PTCT) Announces STRIDE Data Show Translarna Delays Loss of Ambulation by More Than Five Years in Boys with nmDMD
Sep 20, 2021 08:30AM STRIDE Data Show Translarna™ Delays Loss of Ambulation by More Than Five Years in Boys with Nonsense Mutation Duchenne Muscular Dystrophy
Sep 7, 2021 08:00AM PTC Therapeutics Recognizes 2021 STRIVE Awards Recipients for Initiatives Supporting Duchenne Patient Community
Aug 23, 2021 04:30PM PTC Therapeutics (PTCT) Announces Brazilian Approval of Waylivra
Aug 23, 2021 04:30PM PTC Therapeutics Announces Waylivra™ Approval in Brazil as First Treatment for Familial Chylomicronemia Syndrome
Aug 23, 2021 09:00AM Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency
Aug 20, 2021 04:30PM PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 29, 2021 04:00PM PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results
View More Recent Stories View Older Stories